KROS- Keros Therapeutics, Inc.

Name: Keros Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Keros Therapeutics, Inc. (KROS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 128 sells. KROS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Orbimed Advisors LLC	759.2K	$8.09M	-
Dir	Gordon Carl L	759.2K	$8.09M	-
Dir	Knowles Julius	102.2K	$1.09M	-
CEO	Seehra Jasbir	62.5K	$665.6K	-
Dir	Bienaime Jean Jacques	17.6K	$187.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 6, 2021	Knowles Julius62	Director	Sell	9,298	$58.81	$546,840.09	-0.3%	-31.6%	+12.6%
Apr 5, 2021	Knowles Julius62	Director	Sell	38,353	$59.72	$2,290,536.48	-0.5%	-33.3%	+4.8%
Mar 11, 2021	Ordonez Claudia65	Chief Medical Officer	Sale+OE	1,000	$64.56	$64,555.85	-62.3%	-19.3%	-18.8%
Mar 11, 2021	Lachey Jennifer69	Chief Scientific Officer	Sale+OE	5,300	$64.48	$341,749.53	-2.8%	-19.3%	-18.8%
Mar 4, 2021	Knowles Julius62	Director	Sell	23,959	$56.45	$1,352,499.35	-0.3%	-	-
Mar 2, 2021	Knowles Julius62	Director	Sell	23,690	$61.13	$1,448,077.87	-0.2%	-	-
Feb 18, 2021	Knowles Julius62	Director	Sell	28,617	$60.87	$1,742,043.27	-0.2%	-	-
Feb 12, 2021	Knowles Julius62	Director	Sell	19,029	$63.53	$1,208,935.69	-0.2%	-	-
Feb 11, 2021	Ordonez Claudia65	Chief Medical Officer	Sale+OE	1,000	$64.84	$64,841.29	-37.9%	-	-
Feb 11, 2021	Lachey Jennifer69	Chief Scientific Officer	Sale+OE	5,300	$64.91	$344,016.66	-2.9%	-	-

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC